Molecule to Market: Inside the Outsourcing Space
Emergent recently had the pleasure of participating in the Molecule to Market Podcast hosted by Ramen Sehgal from from...
What We Do
Wherever you might be in the drug product lifecycle, Emergent CDMO stands ready to put our resources, technology, and experience to work for you.
We understand that which approach fits you best can be found where science and business strategy intersect, where dynamics like speed, cost, and regulatory approach are balanced in precise harmony. And as an integrated CDMO with the experience of an established biopharmaceutical company, Emergent stands ready to help guide and advance your team down the straightest, smoothest development and manufacturing pathway.
Development
Services
Our clients have come to rely on Emergent CDMO for a broad range of development services, including process development for drug substance and drug product, and analytical development. Whether your program is in clinical or commercial phases, just starting up or scaling for growth, our development services are primed to plug in right where you need them.
Drug Substance Manufacturing
When your unique science connects with our drug substance capabilities, promising opportunities abound. We tailor our suite of technology platforms (mammalian, microbial, plasma protein, and viral) to meet your precise needs. Then we leverage our resources capacity to support your goals.
Learn more about our Drug Substance Manufacturing capabilities
Drug Product Manufacturing
Leveraging both viral and non-viral technologies, our drug product manufacturing capabilities are designed to support all phases of your product lifecycle. Whether you need small volumes of material for clinical research or large-scale manufacturing for a commercialized product, Emergent CDMO has the production, filling, and packaging expertise to support your growth and scale-up, now and in the future.
Learn more about our Drug Product Manufacturing capabilities
In the News
Technology platforms for
every molecule
Global health risks. Rare disease therapeutics. Novel medicines. No matter where your innovation is centered, you'll find us a like-minded and more-than-capable partner. And, no matter where we begin with your project, we maintain a holistic perspective as we help you accelerate along your process development and manufacturing pathway.
Phase
Technologies
Molecule Types
The Power of the
Emergent Way
“The Emergent Way” is visible in everything we do for you. The elements that define it aren’t labeled that way, of course, but you’ll see the hallmarks of what make us different at every turn.
Perfecting Your Formula
Your formula for success if just that - yours. Our size and operating philosophy afford us the ability to assemble the experts, services and technologies in the configurations that best meet your development and manufacturing needs.
Efficient Tech Transfer
At Emergent, our cross-functional teams arm you with the single most valuable asset you can have during tech transfers: confidence. We reduce risk by sticking to proven processes and by not just keeping you apprised of what we’re doing, but how and why we’re doing it.
Agility and Reliability
Our team is dedicated to the art and science of “efficient excellence,” and we incorporate that into everything we do for you. That means we lean toward your interests and not away, and that you can count on us in both the most ordinary and most extraordinary of circumstances.
Passion for the Vision
Every organization says the same thing. We get that. But not every company has a goal of protecting or enhancing a billion lives (which is what we aim to do by 2030). You’ll feel that enthusiasm, focus and dedication when you collaborate with your Emergent CDMO team.
Partnership Thinking
We have a long-haul perspective on client relationships. We take our role and responsibility as an extended member of your team seriously and prioritize confidentiality throughout the process of working with you. Sharing in your success is what fuels ours, time and again.
Entrepreneurial Spririt
At Emergent, we particularly prize “What if?” thinking. And whether they fill whiteboards or bioreactors every day, our professionals are encouraged to consider how every aspect of what we do can be improved — to your benefit and to the benefit of your patients.
Emergent By The Numbers
-
10 Global CDMO facilities on two continents
-
40+ Commercial manufacturing programs supported
-
200+ Clinical
candidates supported -
20+ Years of development & mfg. experience
-
70+ Global CDMO clients
-
7 fill lines available for CDMO clients
Let’s Start A Conversation
Connect now
Connect with us
If you are interested in working with Emergent, want to find out more information about our CDMO services, or would like to have us contact you for any reason, please use this web form to send us your information or questions.